BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30055965)

  • 1. Role of TGF-β1/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma.
    Hu B; Mao Z; Jiang X; He D; Wang Z; Wang X; Zhu Y; Wang H
    Brain Res; 2018 Nov; 1698():204-212. PubMed ID: 30055965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.
    Hu B; Mao Z; Du Q; Jiang X; Wang Z; Xiao Z; Zhu D; Wang X; Zhu Y; Wang H
    Brain Res Bull; 2019 Jul; 149():21-31. PubMed ID: 30946881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
    Li Z; Liu Q; Li C; Zong X; Bai J; Wu Y; Lan X; Yu G; Zhang Y
    Mol Cell Endocrinol; 2015 Feb; 402():64-71. PubMed ID: 25578603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondin-1 and transforming growth factor-β1 levels in prolactinoma and their clinical significance.
    Jiang M; Mou CZ; Han T; Wang M; Yang W
    J Int Med Res; 2012; 40(4):1284-94. PubMed ID: 22971480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.
    Recouvreux MV; Lapyckyj L; Camilletti MA; Guida MC; Ornstein A; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
    Endocrinology; 2013 Nov; 154(11):4192-205. PubMed ID: 24008346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
    Wang S; Wang A; Zhang Y; Zhu K; Wang X; Chen Y; Wu J
    BMC Endocr Disord; 2021 Nov; 21(1):235. PubMed ID: 34814904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance training-induced muscle hypertrophy is mediated by TGF-β1-Smad signaling pathway in male Wistar rats.
    Nikooie R; Jafari-Sardoie S; Sheibani V; Nejadvaziri Chatroudi A
    J Cell Physiol; 2020 Jul; 235(7-8):5649-5665. PubMed ID: 31960436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
    Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
    Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.
    Faraoni EY; Camilletti MA; Abeledo-Machado A; Ratner LD; De Fino F; Huhtaniemi I; Rulli SB; Díaz-Torga G
    J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.
    Jian M; Du Q; Zhu D; Mao Z; Wang X; Feng Y; Xiao Z; Wang H; Zhu Y
    J Endocrinol Invest; 2019 Jun; 42(6):639-652. PubMed ID: 30370446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
    Pan R; Zhang Y; Zang B; Tan L; Jin M
    J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
    Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
    Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
    Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
    PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor β1 is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study).
    Elenkova A; Atanassova I; Kirilov G; Vasilev V; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2013 Sep; 169(3):299-306. PubMed ID: 23801826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β1/Smad3 Signaling Pathway Mediates T-2 Toxin-Induced Decrease of Type II Collagen in Cultured Rat Chondrocytes.
    Li Y; Zou N; Wang J; Wang KW; Li FY; Chen FX; Sun BY; Sun DJ
    Toxins (Basel); 2017 Nov; 9(11):. PubMed ID: 29113082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hUMSCs regulate the differentiation of ovarian stromal cells via TGF-β
    Cui L; Bao H; Liu Z; Man X; Liu H; Hou Y; Luo Q; Wang S; Fu Q; Zhang H
    Stem Cell Res Ther; 2020 Sep; 11(1):386. PubMed ID: 32894203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
    Hsieh YP; Chen HM; Lin HY; Yang H; Chang JZ
    J Formos Med Assoc; 2017 Feb; 116(2):107-113. PubMed ID: 26922429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ALK5/Smad2/3 and MEK1/ERK Signaling in Transforming Growth Factor Beta 1-modulated Growth, Collagen Turnover, and Differentiation of Stem Cells from Apical Papilla of Human Tooth.
    Chang HH; Chang MC; Wu IH; Huang GF; Huang WL; Wang YL; Lee SY; Yeh CY; Guo MK; Chan CP; Hsien HC; Jeng JH
    J Endod; 2015 Aug; 41(8):1272-80. PubMed ID: 26001858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper oxide nanoparticles induce collagen deposition via TGF-β1/Smad3 signaling in human airway epithelial cells.
    Ko JW; Shin NR; Park JW; Park SH; Lee IC; Kim JS; Kim JC; Ahn KS; Shin IS
    Nanotoxicology; 2018 Apr; 12(3):239-250. PubMed ID: 29383958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.